Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database

• Main Authors: Misaki Tokunaga (Author), Daisuke Kikuchi (Author), Aoi Noda (Author), Sachiko Oikawa (Author), Makoto Shiozawa (Author), Hiroaki Hino (Author), Ryosuke Miura (Author), Kensuke Usui (Author), Taku Obara (Author), Kouji Okada (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Abnormal behavior after oseltamivir administration has been reported in the media; in 2007, the package insert for oseltamivir phosphate was revised to restrict its administration to individuals aged over 10 years. However, in 2018, the age limitation specified in the package ins...